| 產(chǎn)品名稱 | Lamotrigine |
| 產(chǎn)品貨號(hào) | Axon 1353 CAS [84057-84-1] MF C9H7Cl2N5MW 256.09 Purity: 99% Soluble in DMSO Description Glutamate antagonist and sodium channel blocker; an anticonvulsant drug References Certificates Categories Extra info L Barbosa et al. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.?J. Clin. Psychiatry. 2003, 6(4), 403–407. ? WJ Curry and DL Kulling. Newer Antiepileptic Drugs: Gabapentin, Lamotrigine, Felbamate, Topiramate and Fosphenytoin. Am. Fam. Physician. 1998, 57(3), 513. Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation NMDA Unclassified Glutamate antagonist; Na+ channel blocker Chemical name 6-(2,3-Dichloro-phenyl)-[1,2,4]tria zine-3,5-diamine Parent CAS No. [84057-84-1] Order Size Unit Price Stock 10 mg €60.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
LamotrigineAxon 1353 CAS [84057-84-1] MF C9H7Cl2N5
Description
Glutamate antagonist and sodium channel blocker; an anticonvulsant drug
Glutamate antagonist; Na+ channel blocker
Chemical name6-(2,3-Dichloro-phenyl)-[1,2,4]tria zine-3,5-diamine Parent CAS No.[84057-84-1] |
| 產(chǎn)品資料 |
